Raloxifene can cut fracture riskBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7208.470b (Published 21 August 1999) Cite this as: BMJ 1999;319:470
- Scott Gottlieb
- New York
Raloxifene, a drug taken to prevent osteoporosis, has been found to increase bone mineral density in the spine and hip and to reduce spinal fracture in postmenopausal women with the disease, according to a new study. Researchers studied 7705 women aged 31 to 80 to determine the effect of raloxifene treatment on the risk of vertebral and non-vertebral fractures …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial